Oncology catalog

Intuca 150mg Tablet contains tucatinib, a targeted tyrosine kinase inhibitor used in the treatment and management of HER2-positive breast cancer, particularly in advanced or metastatic stages. Tucatinib works by blocking specific enzymes involved in the growth and spread of cancer cells, helping to slow disease progression and improve patient outcomes. This medicine is an important part of specialist-led oncology treatment plans and may be used in combination with other anticancer therapies under close supervision. Dosage and treatment schedules are tailored by an oncologist based on the individual patient’s condition, disease stage, and response to therapy to ensure safety and effectiveness.